DEF 14A Filing

Company

INTERPACE BIOSCIENCES, INC.

Filed

June 10, 2020

Period of Report

June 9, 2020

Accession Number

0001493152-20-010891

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →